1. Home
  2. BHC vs BDJ Comparison

BHC vs BDJ Comparison

Compare BHC & BDJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bausch Health Companies Inc.

BHC

Bausch Health Companies Inc.

HOLD

Current Price

$4.95

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Blackrock Enhanced Equity Dividend Trust

BDJ

Blackrock Enhanced Equity Dividend Trust

HOLD

Current Price

$9.20

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHC
BDJ
Founded
N/A
2005
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
BHC
BDJ
Price
$4.95
$9.20
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$8.00
N/A
AVG Volume (30 Days)
1.6M
473.0K
Earning Date
04-29-2026
01-01-0001
Dividend Yield
N/A
8.85%
EPS Growth
423.08
N/A
EPS
N/A
N/A
Revenue
$8,724,000,000.00
N/A
Revenue This Year
$4.61
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.61
$8.42
52 Week High
$8.69
$9.76

Technical Indicators

Market Signals
Indicator
BHC
BDJ
Relative Strength Index (RSI) 30.90 53.18
Support Level $4.93 $8.89
Resistance Level $6.31 $9.24
Average True Range (ATR) 0.20 0.11
MACD -0.04 0.01
Stochastic Oscillator 2.99 68.84

Price Performance

Historical Comparison
BHC
BDJ

About BHC Bausch Health Companies Inc.

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.

About BDJ Blackrock Enhanced Equity Dividend Trust

BlackRock Enhanced Equity Dividend Trust is a United States closed-end management investment company. Its investment objective is to seek current income and current gains, with a secondary objective of long-term capital appreciation.

Share on Social Networks: